Evidence map›Paper›PMID 30846529›Full record

ReviewJournal of lipid research2019

Advances in determining signaling mechanisms of ceramide and role in disease.

Jeffrey L Stith, Fabiola N Velazquez, Lina M Obeid

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of lipid research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.

  1. Sphingolipids in Gaucher disease: a systematic review.Orphanet journal of rare diseases · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Ceramides versus standard methods in prediction of subclinical atherosclerosis.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2026
    Article
  7. Observational
  8. Review
  9. Observational
  10. ORMDL Proteins Turnover via Proteasome and Autophagy Is Cell-Type Dependent and Tied to Ceramide Homeostasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Atherogenic Dyslipidemia and Its Association withInternational journal of molecular sciences · 2025
    Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeffrey L StithStony Brook Cancer Center and the Department of Medicine, Health Sciences Center, Stony Brook University, Stony Brook, NY 11794.
Fabiola N VelazquezStony Brook Cancer Center and the Department of Medicine, Health Sciences Center, Stony Brook University, Stony Brook, NY 11794.
Lina M ObeidStony Brook Cancer Center and the Department of Medicine, Health Sciences Center, Stony Brook University, Stony Brook, NY 11794; Northport Veterans Affairs Medical Center Northport, NY 11768. Electronic address: lina.obeid@stonybrookmedicine.edu.
Stony Brook University · US

Funding

Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI YUSUF AWNI HANNUN · 2003 to 2026
$30.8M
Sphingosine Phosphate Role in InflammationR01GM062887 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OBEID, LINA M · 2001 to 2009
$2.1M
NCI NIH HHS P01 CA097132NIGMS NIH HHS R01 GM062887
6 · The paper itself

Abstract

Ceramide is a critical bioactive lipid involved in diverse cellular processes. It has been proposed to regulate cellular processes by influencing membrane properties and by directly interacting with effector proteins. Advances over the past decade have improved our understanding of ceramide as a bioactive lipid. Generation and characterization of ceramide-metabolizing enzyme KO mice, development of specific inhibitors and ceramide-specific antibodies, use of advanced microscopy and mass spectrometry, and design of synthetic ceramide derivatives have all provided insight into the signaling mechanisms of ceramide and its implications in disease. As a result, the role of ceramide in biological functions and disease are now better understood, with promise for development of therapeutic strategies to treat ceramide-regulated diseases.

Indexed as

Signal TransductionAnimalsCarrier ProteinsCeramidesHeart DiseasesHumansInflammatory Bowel DiseasesMiceMice, KnockoutMultiple SclerosisNeoplasmsNervous System DiseasesObesityCarrier ProteinsCeramidesaginganimal modelscancerheart diseaselipidomicslipid signalingmembrane/fluiditymultiple sclerosisobesityreceptors/plasma membrane

Identifiers

PMID30846529
PMCPMC6495170
OpenAlexW2921960717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.